首页 | 本学科首页   官方微博 | 高级检索  
     


Lymphokines inhibit macrophage RNA synthesis
Authors:L Varesio  H J Issaq  R Kowal  E Bonvini  D Taramelli
Affiliation:1. Biological Therapeutics Branch, Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research Facility, Frederick, Maryland 21701 USA;2. Chemical Synthesis and Analysis Laboratory, National Cancer Institute-Frederick Cancer Research Facility, Frederick, Maryland 21701 USA;3. National Cancer Institute, Division of Experimental Oncology, Milan, Italy
Abstract:The effects of lymphokine (LK) preparations on the incorporation of [3H]uridine into macrophage RNA were investigated. Supernatants from murine spleen cells activated in vitro by alloantigens or Con A, and shown to contain macrophage-activating factor (MAF), were used as the source of LK. It was observed that such LK preparations contain factor(s) causing a profound inhibition of [3H]uridine incorporation into the RNA of proteose-peptone-elicited peritoneal macrophages. Such RNA-labeling inhibitory factor (RIF) was absent in control supernatants from nonstimulated cultures, and showed activation curves similar to that of MAF. RIF activity was not due to altered permeability of macrophages to [3H]uridine nor to the changes in the specific activity of the pool of RNA precursors, but rather reflected an altered metabolism of RNA. The inhibition of RNA synthesis was dependent upon the presence of nanogram amounts of LPS as a costimulator. Moreover, the response to RIF appeared to be genetically controlled since macrophages from C3H/HeJ mice were not affected by RIF, while C3H/HeN mice were fully responsive. In parallel cultures of macrophages, LK were also tested for their MAF activity, and a strong similarity between the biological conditions in which MAF and RIF activities were expressed could be demonstrated. The assay for RIF provides a new and convenient parameter for measuring macrophage-sensitive LK activity that might be very useful for monitoring purification or for screening of T-cell hybridoma supernatants.
Keywords:To whom correspondence should be addressed: NCI-FCRF   P.O. Box B   Frederick   Md. 21701.
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号